Heterocyclic pyrimidine derivatives as promising antibacterial agents

Eur J Med Chem. 2023 Nov 5:259:115701. doi: 10.1016/j.ejmech.2023.115701. Epub 2023 Aug 5.

Abstract

Antibiotic resistance is a growing public health concern. The quest to understand the underlying mechanisms of drug resistance needs to be accompanied by an expanded arsenal of drugs. This calls for the development of new compounds with anti-bacterial properties. The ease of functionalization of the pyrimidine core, to produce structurally distinct compound libraries, has made pyrimidine a privileged structure for identifying anti-bacterial hits. The activity of pyrimidine derivatives can be attributed to the various subunits linked with the main core, especially at C-2 or C-4 or C-6. Particularly, presence of NH2 attached to C-2 of the pyrimidine nucleus has been shown to enhance the anti-bacterial activity against pathogenic Gram-positive and Gram-negative bacteria. The diversity of synthetic routes used for the synthesis of such compounds, the reported biological activities, and a growing need to develop novel anti-bacterial agents warrant a review that presents recent reports on the synthesis and anti-bacterial activities of pyrimidine-containing compounds.

Keywords: Anti-bacterial; Antibiotics; Multidrug-resistant; Pyrimidine; Pyrimidine derivatives.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Antihypertensive Agents
  • Cell Nucleus
  • Gram-Negative Bacteria*
  • Gram-Positive Bacteria

Substances

  • Anti-Bacterial Agents
  • Antihypertensive Agents